2.27
price down icon9.92%   -0.25
after-market Dopo l'orario di chiusura: 2.33 0.06 +2.64%
loading
Precedente Chiudi:
$2.52
Aprire:
$2.4
Volume 24 ore:
859.18K
Relative Volume:
1.04
Capitalizzazione di mercato:
$74.05M
Reddito:
-
Utile/perdita netta:
$-29.25M
Rapporto P/E:
-1.914
EPS:
-1.186
Flusso di cassa netto:
$-22.80M
1 W Prestazione:
-39.63%
1M Prestazione:
-34.20%
6M Prestazione:
-44.90%
1 anno Prestazione:
-58.20%
Intervallo 1D:
Value
$2.22
$2.43
Intervallo di 1 settimana:
Value
$2.22
$3.93
Portata 52W:
Value
$2.22
$7.38

Sagimet Biosciences Inc Stock (SGMT) Company Profile

Name
Nome
Sagimet Biosciences Inc
Name
Telefono
(650) 561-8600
Name
Indirizzo
155 BOVET RD., SUITE 303, SAN MATEO
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SGMT's Discussions on Twitter

Confronta SGMT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SGMT
Sagimet Biosciences Inc
2.27 74.05M 0 -29.25M -22.80M -1.186
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 125.55B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 67.78B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 36.24B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.99B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.77B 3.81B -644.79M -669.77M -6.24

Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-06 Iniziato Oppenheimer Outperform
2024-11-12 Iniziato UBS Buy
2024-06-28 Downgrade Goldman Buy → Neutral
2024-05-02 Iniziato H.C. Wainwright Buy
2024-03-25 Iniziato Leerink Partners Outperform
2023-08-08 Iniziato Goldman Buy
2023-08-08 Iniziato JMP Securities Mkt Outperform
2023-08-08 Iniziato Piper Sandler Overweight
2023-08-08 Iniziato TD Cowen Outperform
Mostra tutto

Sagimet Biosciences Inc Borsa (SGMT) Ultime notizie

pulisher
09:16 AM

Holdings of Sagimet Biosciences Inc (SGMT) are aligned with the stars - Sete News

09:16 AM
pulisher
Mar 31, 2025

Virtu Financial LLC Sells 9,123 Shares of Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Mar 31, 2025
pulisher
Mar 20, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives $23.00 Consensus Price Target from Analysts - Defense World

Mar 20, 2025
pulisher
Mar 17, 2025

HC Wainwright Issues Positive Estimate for SGMT Earnings - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Sagimet Biosciences (SGMT) Expected to Announce Earnings on Monday - Defense World

Mar 17, 2025
pulisher
Mar 13, 2025

Sagimet Biosciences: Promising Future with Phase 3 MASH Trials and Strong Financial Position - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

HC Wainwright Reiterates Buy Rating for Sagimet Biosciences (NASDAQ:SGMT) - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Sagimet Biosciences Faces AI Integration Challenges: Security, Compliance, and Cost Risks Loom - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Sagimet Biosciences Advances MASH Treatment with New Trials - TipRanks

Mar 13, 2025
pulisher
Mar 12, 2025

Sagimet Biosciences Reports Full Year 2024 Financial Results and Provides Corporate Updates - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Sagimet’s FASN inhibitor cleared to enter clinic for acne - BioWorld MedTech

Mar 12, 2025
pulisher
Mar 12, 2025

Sagimet Biosciences Inc. (SGMT) reports earnings - Quartz

Mar 12, 2025
pulisher
Mar 12, 2025

Sagimet Biosciences Inc. SEC 10-K Report - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Sagimet's FDA Breakthrough Drug Enters Phase 3 Trials with $158M War Chest - StockTitan

Mar 12, 2025
pulisher
Mar 12, 2025

Promising Developments in Sagimet Biosciences: IND Clearance for TVB-3567 and Ongoing Success of Denifanstat - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Promising Pipeline and Positive Trial Data Support Buy Rating for Sagimet Biosciences - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567 - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Sagimet Reports Acne Drug Candidate Cleared for Clinical Trials -March 11, 2025 at 10:46 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Sagimet Biosciences receives FDA nod to begin testing its therapy for acne -March 11, 2025 at 09:38 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for the Treatment of Acne - SEC.gov

Mar 11, 2025
pulisher
Mar 11, 2025

Sagimet Biosciences announces clearance of IND for FASN inhibitor TVB-3567 - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Sagimet Biosciences Announces Clearance of IND for FASN - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Sagimet Biosciences Announces Clearance of IND for FASN Inhibitor TVB-3567, to be Developed for ... - The Bakersfield Californian

Mar 11, 2025
pulisher
Mar 11, 2025

FDA Clears Groundbreaking Acne Drug: Sagimet's New FASN Inhibitor Targets 50M Patient Market - StockTitan

Mar 11, 2025
pulisher
Mar 07, 2025

Sagimet Biosciences’ Denifanstat Should Be Worth More Today (NASDAQ:SGMT) - Seeking Alpha

Mar 07, 2025
pulisher
Feb 25, 2025

Is Sagimet Biosciences Inc. (SGMT) the Best Get Rich Quick Stock to Invest In? - Insider Monkey

Feb 25, 2025
pulisher
Feb 24, 2025

10 Best Get Rich Quick Stocks To Invest In - Insider Monkey

Feb 24, 2025
pulisher
Feb 23, 2025

Brokerages Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $23.00 - Defense World

Feb 23, 2025
pulisher
Feb 22, 2025

10 Hot Penny Stocks to Buy Now - Insider Monkey

Feb 22, 2025
pulisher
Feb 22, 2025

Unveiling Hidden Gems: The Hot Penny Stock You Might Be Missing - Reporteros del Sur -

Feb 22, 2025
pulisher
Feb 22, 2025

Sagimet Biosciences Inc. (SGMT): Among the Hot Penny Stocks to Buy Now - Insider Monkey

Feb 22, 2025
pulisher
Feb 21, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 21, 2025
pulisher
Feb 19, 2025

Sagimet Biosciences Announces Oral Presentation at the MASH - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Sagimet Biosciences Announces Oral Presentation at the MASH Pathogenesis and Therapeutic ... - The Bakersfield Californian

Feb 19, 2025
pulisher
Feb 19, 2025

Could This New MASH Drug Transform Liver Disease Treatment? Key Phase 2b Results Revealed - StockTitan

Feb 19, 2025
pulisher
Feb 14, 2025

FY2024 Earnings Estimate for SGMT Issued By Leerink Partnrs - MarketBeat

Feb 14, 2025
pulisher
Feb 11, 2025

Technical analysis of Sagimet Biosciences Inc (SGMT) stock chart patterns - US Post News

Feb 11, 2025
pulisher
Feb 11, 2025

FY2024 Earnings Forecast for SGMT Issued By Leerink Partnrs - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Keeping an Eye on Sagimet Biosciences Inc (SGMT) After Insider Trading Activity - Knox Daily

Feb 10, 2025
pulisher
Feb 08, 2025

Sagimet Biosciences Inc (NASDAQ:SGMT) Up 47.7% Since 52-Week Low; YTD Rose 1.56% – Here’s What You Need To Do – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 08, 2025

Equities Analysts Issue Forecasts for SGMT FY2029 Earnings - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

Prepare Yourself for Liftoff: Sagimet Biosciences Inc (SGMT) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Sagimet Biosciences Inc (SGMT)’s results reveal risk - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Analytical Overview: Sagimet Biosciences Inc (SGMT)’s Ratios Tell a Financial Story - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

US Penny Stocks Spotlight: Gevo And 2 Other Promising Picks - Yahoo Finance

Feb 04, 2025
pulisher
Feb 03, 2025

Buy Recommendation for Sagimet Biosciences: Denifanstat’s Unique Profile and Undervaluation Offer Compelling Investment Opportunity - TipRanks

Feb 03, 2025
pulisher
Feb 02, 2025

What's Going On With Sagimet Biosciences Stock On Thursday? - MSN

Feb 02, 2025
pulisher
Feb 01, 2025

JPMorgan Chase & Co. Boosts Stake in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

Feb 01, 2025
pulisher
Feb 01, 2025

Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 01, 2025

Sagimet Biosciences Inc Azioni (SGMT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Capitalizzazione:     |  Volume (24 ore):